Ascendis wins U.S. approval for therapy for children with dwarfism
ReutersFeb 27, 2026 11:01 PM
Feb 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved Ascendis Pharma's A71.F once-weekly therapy for children with a rare genetic disorder that causes dwarfism, the company said.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Meta’s TPU Deal with Google: What It Means for Nvidia
TradingKey - According to a news from The Information on Thursday, citing people familiar with the matter, Meta Platforms Inc. (META) and Alphabet Inc. (GOOGL) have reached a multiyear, multibillion‑dollar AI‑chip partnership under which Meta will lease Google’s custom‑built TPUs (Tensor ProcessingTradingKey
16 hours ago
The Hotter AI Gets, the More Attractive “Bricks” Become? Wall Street's HALO Craze Turns Heavy Assets Red-Hot
TradingKey - As AI technology continues to lower the barriers to replication for virtual products, global asset pricing logic is undergoing a subtle shift—tangible assets rooted in the physical world that are difficult to replace digitally are regaining significant favor from capital. This trend hasTradingKey
17 hours ago
Ethereum Fails to Hit $2,200. Will ETH Hit New Lows Again in 2026?
Ethereum retreats after testing $2,200: Will it continue to drop and hit new lows?TradingKey
19 hours ago
Nvidia Q4 Earnings Beat Expectations but Stock Plunges 5.5%, $260 Billion in Market Value Erased Overnight, Why Are Investors Voting With Their Feet?
TradingKey - On February 25, 2026, global AI chip leader Nvidia (NVDA) released its fiscal 2026 fourth-quarter earnings report. Revenue, net profit, and data center business all significantly exceeded Wall Street consensus expectations, delivering a "stellar" set of results.TradingKey
19 hours ago
Deconstructing Citrini’s “2028 Global Intelligence Crisis”: S&P 8000 Bait and the Game Logic of Technological Deflation
A deep deconstruction of the 2026 AI-driven wealth migration logic, analyzing the paradox between the unemployment wave warnings and the S&P 8,000 projection in the Citrini report. Through core case studies such as Microsoft’s valuation mean reversion and Amazon AWS’s computing power dividends, this article reveals high-conviction investment opportunities in "physical layer" assets against a backdrop of technological deflation.TradingKey
22 hours ago
